Study: Delirium Can Signal COVID-19 in Older, Asymptomatic Patients in Emergency Department
December 8th 2020Delirium was the sixth most common presenting symptom in all patients, suggesting the clinical importance of including delirium on checklists of presenting signs and symptoms for COVID-19.
Read More
APhA Survey Results Finds Pharmacists Ready to Receive, Administer COVID-19 Vaccines
December 4th 2020A recent nationwide survey of 400 pharmacists conducted by the American Pharmacists Association (APhA) found that more than three-fourths of pharmacists plan to be vaccinated with 1 of the coronavirus disease 2019 (COVID-19) vaccines.
Read More
Pharmacists Address Pediatrician, Anti-Vaxxer Concerns Over Childhood Vaccinations
December 3rd 2020Following authorization allowing pharmacists to administer childhood vaccines, some pediatricians have expressed concerns that this deprives children of medical care or could lead to missed vaccines.
Read More
Study: COVID-19 May Deepen Depression, Anxiety, and PTSD Among Pregnant, Postpartum Women
December 3rd 2020The researchers launched the Perinatal Experiences and COVID-19 Effects Study to better understand the mental health and well-being of pregnant and postpartum individuals within the United States during the COVID-19 pandemic.
Read More
Study: Cancer Survivors at Higher Risk of Hospitalization, Death from Flu
December 3rd 2020Further, the findings suggest that cancer survivors are also likely to be at an increased risk of severe coronavirus disease 2019 (COVID-19) outcomes, given that both influenza and COVID-19 are both epidemic respiratory viruses.
Read More
Irinotecan Liposome Injection Gets FDA Fast Track Designation for Second-Line Small Cell Lung Cancer
December 3rd 2020FDA grants fast track designation to irinotecan liposome injection (Onivyde; MM-398) as second-line monotherapy for patients with small cell lung cancer whose disease progressed following a platinum-based chemotherapy regimen.
Read More